title: Epidemiology of human immunodeficiency virus-associated pulmonary disease.
abstract: HIV/AIDS was initially characterized as a progressively worsening disorder of cellular immunosuppression. In 1996, HIV/AIDS was separated into 2 diagnostic, management, prognostic categories: high-income and low-income groups. High-income people with HIV have had access to antiretroviral therapeutic agents, which have transformed HIV from a lethal to an indolent disease, with life expectancy comparable with other chronic conditions. About 50% of low-income people with HIV who are candidates for antiretroviral therapy actually receive it. Since 1996, the principal HIV-associated pulmonary disease in high-income countries has changed from Pneumocystis pneumonia to community-acquired pneumonia; tuberculosis has predominated in low-income countries as long as HIV has prevailed.
authors.affiliation: Pulmonary, San Francisco General Hospital, University of California San Francisco, San Francisco, CA 94134-0841, USA. johnfmurr4@aol.com
authors.forename: John F
authors.initials: JF
authors.lastname: Murray
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000453:epidemiology*; D017714:Community-Acquired Infections / Q000453:epidemiology; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D008171:Lung Diseases / Q000453:epidemiology* / Q000209:etiology; D008297:Male; D018410:Pneumonia, Bacterial / Q000453:epidemiology; D011020:Pneumonia, Pneumocystis / Q000453:epidemiology; D014397:Tuberculosis, Pulmonary / Q000453:epidemiology